Coeptis Therapeutics Holdings, Inc. - Warrants COEPW 深 沪
已收盘 08-01 16:00:00 美东时间
0.0286
-0.001
-2.72%
华盛通- 最 高0.0296
- 今 开0.0296
- 成交量 3.22万股
- 最 低 0.0198
- 昨 收 0.0294
- 总市值 0
- 52周最高 0.0599
- 市盈率 静 --
- 换手率 Infinity.00%
- 52周最低 0.0042
- 委 比 -44.79%
- 总股本 --
- 历史最高 1.74
- 量 比 0.23
- 振 幅 33.33%
- 历史最低 0.0042
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger: COEP, RHE, PPBI, and PORT
NEW YORK, July 3, 2025 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders...
07-04 05:31
Coeptis Therapeutics Files Form S-4 With SEC For Proposed Merger With Z Squared
Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) ("Coeptis" or the "Company"), a next-gen technology and biopharmaceutical company, is pleased to announce the filing of a registration statement on Form S-4 with the
06-26 20:37
SNAP Biosciences & Monarch Therapeutics Partner To Advance Snap-Car NK Cell Therapy
SNAP Biosciences, Inc a majority-owned subsidiary of Coeptis Therapeutics Holdings Inc. (NASDAQ:COEP) and Monarch Therapeutics Inc., a biotechnology company pioneering next-generation immunotherapies, today announced a
05-28 20:29
Dogecoin Up 9% In One Week: Is A Breakout Coming?
Dogecoin (CRYPTO: DOGE) is up 9% over the past week, with key technical signals suggesting a possible breakout.
04-29 19:55
Coeptis Therapeutics, Z Squared announce merger agreement
Coeptis Therapeutics (NASDAQ:COEP) and Z Squared have entered into a definitive merger agreement that will result in Z Squared becoming a wholly-owned subsidiary of Coeptis. Under the terms of the mer...
04-25 21:08
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Harrow (NASDAQ:HROW) stock moved upwards by 15.8% to $27.0 during Mond...
03-18 05:05
Coeptis Therapeutics Secures Worldwide Development And Commercialization Rights To GEAR Cell Therapy Platform
• COEP forms GEAR Therapeutics, as a majority-owned subsidiary, to advance GEAR-modified natural killer (NK) cells into first-in-human studies for broad range of cancers and other therapeutic modalities.
03-11 20:35
Coeptis Therapeutics Regains Compliance With Nasdaq Listing Rules
Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) (the "Company" or "Coeptis"), a biopharmaceutical company focused on pioneering cell therapy platforms for cancer, autoimmune, and infectious diseases, today announced it
01-22 21:04
快讯 | Coeptis Therapeutics Holdings Inc向SEC提交申请，出售多达392万股股份，销售股东为其出售。
Coeptis Therapeutics Holdings Inc Files for Resale of up to 3.92 Mln Shares by ...
01-11 06:02
Coeptis Therapeutics announces reverse stock split
Coeptis Therapeutics (NASDAQ:COEP) on Friday said it will proceed with a 1-for-20 reverse stock split of its issued and outstanding shares of common stock. The first day of trading on a post-split bas...
2024-12-27 21:51
